Abstract:Objective To investigate the different effects of an angiotensin R type 1 (AT(1)) receptor antagonist, losartan, and an angiotensin converting enzyme (ACE) inhibitor, fosinopril, on cardiomyocyte apoptosis, myocardial fibrosis, and angiotensin II (Ang II) in the left ventricle of spontaneously hypertensive rats (SHRs).Methods SHRs of 16-week-old were randomly divided into 3 groups: SHR-L (treated with losartan, 30 mg . kg(-1) . d(-1)), SHR-F (treated with fosinopril, 10 mg . kg(-1) . d(-1)), and SHR-C (treated with placebo). Each group consisted of 10 rats. Five rats, randomly selected from each group, were killed at the 8th and 16th week after treatment. Cardiomyocyte apoptosis, collagen volume fraction ( CVF), perivascular collagen area (PVCA) and Ang II concentrations of plasma and myocardium were examined.Results Compared with the controls at the 8th and 16th week, systolic blood pressures were similarly decreased in both treatment groups. Left ventricular weight and left ventricular mass indexes were significantly lower in both treatment groups. However, the latter parameter at the 16th week was reduced to a less extent in the fosinopril group than that in the losartan group. Compared with the controls, cardiomycyte apoptotic index was significantly reduced at the 8th week only in the fosinopril group, and at the 16th week in both treatment groups. The index of the fosinopril group was lower than that of the losartan group at the latter endpoint examined. Compared with the controls, the left ventricular collagen volume fraction and perivascular collagen area at the 8th and 16th weeks were significantly reduced in the SHRs treated with either fosinopril or losartan. However, the collagen volume fraction at the latter endpoint in the fosinopril group was lower than that in the losartan group. Compared with the controls at endpoints, plasma and myocardium Ang II levels were significantly increased in the losartan group. However, plasma Ang II concentrations were not altered, and myocardium Ang II concentrations at the 8th and 16th weeks were significantly reduced in the fosinopril group.Conclusions Both losartan and fosinopril could effectively inhibit cardiomyocyte apoptosis and myocardial fibrosis and reverse heart hypertrophy. Fosinopril may be more effective in these cardioprotective effects, suggesting that the effects of both drugs are related to the inhibition of myocardium renin-angiotension-aldsterone system.

The Effects of Different Angiotensin II Type 1 Receptor Blockers on the Regulation of the ACE-AngII-AT1 and ACE2-Ang(1–7)-Mas Axes in Pressure Overload-Induced Cardiac Remodeling in Male Mice

Comparison of Angiotensin II Type 1-Receptor Blockers to Regress Pressure Overload-Induced Cardiac Hypertrophy in Mice.

Losartan Reduced Connexin43 Expression in Left Ventricular Myocardium of Spontaneously Hypertensive Rats

Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.

Ace2-Ang (1-7) Axis is Induced in Pressure Overloaded Rat Model

Angiotensin Ii Type 1 Receptor Antagonists in Animal Models of Vascular, Cardiac, Metabolic and Renal Disease

Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects

The Ace2-Ang (1-7)-mas Receptor Axis Attenuates Cardiac Remodeling and Fibrosis in Post-Myocardial Infarction

AT1 Receptor Blocker Inhibits HMGB1 Expression in Pressure Overload-Induced Acute Cardiac Dysfunction by Suppressing the MAPK/NF-κB Signaling Pathway

Involvement of Angiotensin II Type 1 Receptor and Calcium Channel in Vascular Remodeling and Endothelial Dysfunction in Rats with Pressure Overload

Aortic remodeling after transverse aortic constriction in mice is attenuated with AT1 receptor blockade.

GW24-e3170 Angiotensin-(1-7) Downregulates Angiotensin II Type 1 Receptor and Inhibites Mechanical Stress-Induced Cardiomyocyte Autophagy

A Newly Developed Angiotensin II Type 1 Receptor Antagonist, CS866, Promotes Regression of Cardiac Hypertrophy by Reducing Integrin .BETA.1 Expression

Regulation of Angiotensin-(1–7) and Angiotensin II Type 1 Receptor by Telmisartan and Losartan in Adriamycin-Induced Rat Heart Failure

Insights into the Activation and Inhibition of Angiotensin Ii Type 1 Receptor in the Mechanically Loaded Heart

Effect of Losartan on Myocardial Remodeling in Myocardial Infarction Rats’Model

Aortic Remodeling after Transverse Aortic Constriction in Mice is Attenuated with AT1 Receptor Blockade

AT1b receptors contribute to regional disparities in angiotensin II mediated aortic remodelling in mice

AT1Receptor Blockade Improves Myocardial Functional Performance in Obesity

Is overall blockade superior to selective blockade of adrenergic receptor subtypes in suppressing left ventricular remodeling in spontaneously hypertensive rats?

Apoptosis, Myocardial Fibrosis and Angiotensin Ii in the Left Ventricle of Hypertensive Rats Treated with Fosinopril or Losartan